The application of cytokeratin-18 as a biomarker for drug-induced liver injury Samantha KorverJoanne BowenChristopher Goldring Review Article Open access 29 July 2021 Pages: 3435 - 3448
Aryl hydrocarbon receptor (AHR) functions in infectious and sterile inflammation and NAD+-dependent metabolic adaptation Karl Walter Bock Review Article Open access 24 September 2021 Pages: 3449 - 3458
A review of the success and challenges in characterizing human dermal exposure to flame retardants Enzo Zini Moreira SilvaDaniel Junqueira DortaDaniela Morais Leme Review Article 26 August 2021 Pages: 3459 - 3473
Systems analysis of miRNA biomarkers to inform drug safety Amy L. SchofieldJoseph P. BrownChris Goldring Review Article Open access 12 September 2021 Pages: 3475 - 3495
Cadmium induces renal inflammation by activating the NLRP3 inflammasome through ROS/MAPK/NF-κB pathway in vitro and in vivo Ziyin LiHuiqin ChiXingfen Yang Inorganic Compounds 12 September 2021 Pages: 3497 - 3513
Toxicokinetics of di-isodecyl phthalate and its major metabolites in rats through the application of a developed and validated UHPLC-ESI-MS/MS method Seung-Hyun JeongJi-Hun JangYong-Bok Lee Toxicokinetics and Metabolism 06 September 2021 Pages: 3515 - 3537
Cytotoxicity, metabolism, and isozyme mapping of the synthetic cannabinoids JWH-200, A-796260, and 5F-EMB-PINACA studied by means of in vitro systems Tanja M. GampferLea WagmannMarkus R. Meyer In vitro systems Open access 28 August 2021 Pages: 3539 - 3557
Dynamically monitoring cellular γ-H2AX reveals the potential of carcinogenicity evaluation for genotoxic compounds Minmin QuHua XuJianwei Xie Genotoxicity and Carcinogenicity 12 September 2021 Pages: 3559 - 3573
Overcoming the acquired resistance to gefitinib in lung cancer brain metastasis in vitro and in vivo Zhongwei LiuNeal ShahWeimin Gao Genotoxicity and Carcinogenicity 28 August 2021 Pages: 3575 - 3587
Viper venoms drive the macrophages and hepatocytes to sequester and clear platelets: novel mechanism and therapeutic strategy for venom-induced thrombocytopenia Chuanbin ShenMing LiuHeyu Ni Biologics 14 September 2021 Pages: 3589 - 3599
Scientific discrepancies in European regulatory proposals on endocrine disruptors—REACH regulation quo vadis? Andreas Natsch Letter to the Editor, News and Views Open access 10 September 2021 Pages: 3601 - 3609
The codification of hazard and its impact on the hazard versus risk controversy John E. DoeAlan R. BoobisDouglas C. Wolf Letter to the Editor, News and Views Open access 24 September 2021 Pages: 3611 - 3621
